This phenomenon is supported by a recent study indicating that AhR is a key negative regulator of proliferation and tumorigenesis in p53 knockout cancer cells, which was identified by an unbiased genome-wide knockdown approach [158]. The gene discussed is TP53; the disease is cancer.